Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Andreas Lundh

doi:10.1056/NEJMc2100217

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Department of Infectious Diseases

9 Citations (Scopus)

Original language	English
Article number	2100217
Journal	The New England journal of medicine
Volume	384
Issue number	15
Pages (from-to)	1473-1474
Number of pages	2
ISSN	0028-4793
DOIs	https://doi.org/10.1056/NEJMc2100217
Publication status	Published - 15 Apr 2021

Keywords

Antibodies, Monoclonal, Humanized/therapeutic use
COVID-19/drug therapy
Humans
SARS-CoV-2

Access to Document

10.1056/NEJMc2100217

Cite this

@article{07be5783003e47e68314b1ef085ed658,

title = "Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia",

keywords = "Antibodies, Monoclonal, Humanized/therapeutic use, COVID-19/drug therapy, Humans, SARS-CoV-2",

author = "Andreas Lundh",

year = "2021",

month = apr,

day = "15",

doi = "10.1056/NEJMc2100217",

language = "English",

volume = "384",

pages = "1473--1474",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "15",

}

TY - JOUR

T1 - Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

AU - Lundh, Andreas

PY - 2021/4/15

Y1 - 2021/4/15

KW - Antibodies, Monoclonal, Humanized/therapeutic use

KW - COVID-19/drug therapy

KW - Humans

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85103877809&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2100217

DO - 10.1056/NEJMc2100217

M3 - Letter

C2 - 33657286

VL - 384

SP - 1473

EP - 1474

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 15

M1 - 2100217

ER -

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Keywords

Access to Document

Other files and links

Cite this